Abstract Acquired cisplatin resistance limits platinum chemotherapy efficacy in non–small cell lung cancer (NSCLC) and is accompanied by tumor immune microenvironment (TME) remodeling. We integrated public NSCLC single-cell RNA-seq datasets to compare cellular composition and CellChat-inferred communication between post-chemotherapy remission and relapse/resistant tumors, and validated ZUP1 expression and prognostic relevance in TCGA and external cohorts.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile